Vivitra 440 mg Injection
  1. Home
  2. Pharma Products
  3. Cadila Healthcare Ltd
  4. Vivitra 440 mg Injection

Vivitra 440 mg Injection

Vivitra 440 mg Injection contains trastuzumab, a targeted monoclonal antibody used mainly for HER2-positive breast and stomach cancers. It is supplied as a 440 mg powder for injection with diluent and is administered under medical supervision. Trastuzumab targets the HER2 protein and helps slow the growth of HER2-positive cancer cells.

BUY NOW

Category

Vivitra 440 mg Injection is a biosimilar trastuzumab product used in selected HER2-positive breast and gastric cancer treatment protocols. It binds to HER2 receptors on cancer cells and interferes with signals that support their growth and survival. The medicine is administered by a trained healthcare professional according to the prescribed oncology regimen. Patients require monitoring for infusion-related reactions and potential cardiac effects during treatment.

Technical Specification

Specification Details
Active Ingredient Trastuzumab
Strength 440 mg
Dosage Form Powder for Injection
Route of Administration Intravenous Infusion
Pack Size 1 Vial with Diluent
Manufacturer Zydus Lifesciences Limited

Product Also Known As

Vivitra 440 mg Injection, Vivitra 440 Injection, Vivitra Trastuzumab Injection, Trastuzumab 440 mg Injection, Trastuzumab Cancer Injection, HER2 Targeted Cancer Injection